Annals of Diagnostic Pathology
Volume 15, Issue 4 , Pages 286-290 , August 2011

Hematolymphoid malignancies with intraocular intravascular involvement: report of 2 cases

References 

  1. Shafique S, Bona R, Kaplan AA. A case report of therapeutic leukapheresis in an adult with chronic myelogenous leukemia presenting with hyperleukocytosis and leukostasis. Ther Apher Dial. 2007;11(2):146–149
  2. Mudhar HS, Sethuraman C, Khan MD, Jan SU. Intraocular, pan-uveal intravascular large B-cell lymphoma associated with choroidal infarction and choroidal tri-lineage extramedullary haemtopoiesis. Histopathology. 2007;51(2):275–279
  3. Ponzoni M, Arrigoni G, Gould VE, et al. Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol. 2000;31(2):220–226
  4. Porcu P, Cripe LD, Ng EW, et al. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leuk Lymphoma. 2000;39(1-2):1–18
  5. Coupland SE, Damato B. Understanding intraocular lymphomas. Clin Experiment Ophthalmol. 2008;36(6):564–578
  6. Adeoye AO, Durosinmi MA, Adeodu OO, et al. Ocular manifestations of Burkitt's lymphoma: experience in Ile-Ife south western Nigeria. West Afr J Med. 2007;26(1):48–52
  7. Faia LJ, Chan CC. Primary intraocular lymphoma. Arch Pathol Lab Med. 2009 Aug;133(8):1228–1232
  8. Russo V, Scott IU, Querques G, et al. Orbital and ocular manifestations of acute childhood leukemia: clinical and statistical analysis of 180 patients. Eur J Ophthalmol. 2008;18(4):619–623
  9. Person EA, Lyon DB. Rupani MK. Ophthalmic presentation of plasma cell neoplasm. Ophthal Plast Reconstr Surg. Jul-Aug. 2009;25(4):315–316
  10. Burkat CN, Van Buren JJ, Lucarelli MJ. Characteristics of orbital multiple myeloma: a case report and literature review. Surv Ophthalmol. 2009;54(6):697–704
  11. Shields JA, Stopyra GA, Marr BP, et al. Bilateral orbital myeloid sarcoma as initial sign of acute myeloid leukemia: case report and review of the literature. Arch Ophthalmol. 2003;121(1):138–142
  12. Fung S, Selva D, Leibovitch I, Hsuan J. Crompton J. Ophthalmic manifestations of multiple myeloma. Ophthalmologica. 2005;219(1):43–48
  13. Sharma T, Grewal J, Gupta S, Murray PI. Ophthalmic manifestations of acute leukaemias: the ophthalmologist's role. Eye (Lond). 2004;18(7):663–672
  14. Levy-Clarke GA, Greenman D, Sieving PC, et al. Ophthalmic manifestations, cytology, immunohistochemistry, and molecular analysis of intraocular metastatic T-cell lymphoma: report of a case and review of the literature. Surv Ophthalmol. 2008;53(3):285–295
  15. Koenig MK, Sitton CW, Wang M, Slopis JM. Central nervous system complications of blastic hyperleukocytosis in childhood acute lymphoblastic leukemia: diagnostic and prognostic implications. J Child Neurol. 2008;23(11):1347–1352
  16. Blum W, Porcu P. Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome. Semin Thromb Hemost. 2007;33(4):350–354
  17. McKee LC, Collins RD. Intravascular leukocyte thrombi and aggregates as a cause of morbidity and mortality in leukemia. Medicine (Baltimore). 1974;53(6):463–478
  18. Erdur B, Yilmaz S, Oren H, et al. Evaluating pulmonary complications in childhood acute leukemias. J Pediatr Hematol Oncol. 2008;30(7):522–526
  19. Piccirillo N, Laurenti L, Chiusolo P, et al. Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis. Am J Hematol. 2009;84(6):381–382
  20. Thornton KA, Levis M. Images in clinical medicine. FLT3 mutation and acute myelogenous leukemia with leukostasis. N Engl J Med. 2007;357(16):1639
  21. Swerdlow SH, International Agency for Research on Cancer , World Health Organization . In: WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon (France): International Agency for Research on Cancer; 2008;p. 439
  22. Wick MR, Mills SE, Scheithauer BW, et al. Reassessment of malignant “angioendotheliomatosis”. Evidence in favor of its reclassification as “intravascular lymphomatosis”. Am J Surg Pathol. 1986;10(2):112–123
  23. Bhawan J. Angioendotheliomatosis proliferans systemisata: an angiotropic neoplasm of lymphoid origin. Semin Diagn Pathol. 1987;4(1):18–27
  24. Ferry JA, Harris NL, Picker LJ, et al. Intravascular lymphomatosis (malignant angioendotheliomatosis). A B-cell neoplasm expressing surface homing receptors. Mod Pathol. 1988;1(6):444–452
  25. Elner VM, Hidayat AA, Charles NC, et al. Neoplastic angioendotheliomatosis. A variant of malignant lymphoma immunohistochemical and ultrastructural observations of three cases. Ophthalmology. 1986;93(9):1237–1245
  26. Sato T, Goto H, Toratani A, et al. Neoplastic angioendotheliosis presenting Tolosa-Hunt syndrome, intraspinal invasion and intraorbital tumor. Rinsho Ketsueki. 1994;35(6):557–561
  27. Beaubien ER, Wilson TW, Satkunam N. Sudden death in a patient with chronic lymphocytic leukemia. CMAJ. 1998;159(9):1123–1125
  28. van Buchem MA, Wondergem JH, Kool LJ, et al. Pulmonary leukostasis: radiologic-pathologic study. Radiology. 1987;165(3):739–741
  29. Novotny JR, Muller-Beissenhirtz H, Herget-Rosenthal S, Kribben A, Duhrsen U. Grading of symptoms in hyperleukocytic leukaemia: a clinical model for the role of different blast types and promyelocytes in the development of leukostasis syndrome. Eur J Haematol. 2005;74(6):501–510
  30. Stucki A, Rivier AS, Gikic M, et al. Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. Blood. 2001;97(7):2121–2129
  31. Cozzolino F, Rubartelli A, Aldinucci D, et al. Interleukin 1 as an autocrine growth factor for acute myeloid leukemia cells. Proc Natl Acad Sci U S A. 1989;86(7):2369–2373
  32. Rodriguez-Cimadevilla JC, Beauchemin V, Villeneuve L, et al. Coordinate secretion of interleukin-1 beta and granulocyte-macrophage colony-stimulating factor by the blast cells of acute myeloblastic leukemia: role of interleukin-1 as an endogenous inducer. Blood. 1990;76(8):1481–1489
  33. Griffin JD, Rambaldi A, Vellenga E, et al. Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors. Blood. 1987;70(4):1218–1221
  34. Almulki L, Noda K, Nakao S, et al. Localization of vascular adhesion protein-1 (VAP-1) in the human eye. Exp Eye Res. 2010;90(1):26–32
  35. Ambati J, Gragoudas ES, Miller JW, et al. Transscleral delivery of bioactive protein to the choroid and retina. Invest Ophthalmol Vis Sci. 2000;41(5):1186–1191

PII: S1092-9134(10)00065-1

doi: 10.1016/j.anndiagpath.2010.04.006

Annals of Diagnostic Pathology
Volume 15, Issue 4 , Pages 286-290 , August 2011

Article Tools

* Image Usage & Resolution